Technical Analysis for CTMX - CytomX Therapeutics, Inc.

Grade Last Price % Change Price Change
C 8.96 5.04% 0.43
CTMX closed up 5.04 percent on Thursday, April 22, 2021, on 1.26 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CTMX trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
20 DMA Support Bullish 5.04%
Crossed Above 50 DMA Bullish 5.04%
Up 3 Days in a Row Strength 5.04%
Upper Bollinger Band Touch Strength 5.04%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 12.56%
200 DMA Support Bullish 12.56%
Crossed Above 20 DMA Bullish 12.56%
MACD Bullish Signal Line Cross Bullish 12.56%
Older End-of-Day Signals for CTMX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 8 hours ago
Up 3% about 9 hours ago
Rose Above Previous Day's High about 10 hours ago
Up 2% about 10 hours ago
Up 1% about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., and ImmunoGen, Inc. to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Sutro Biopharma Bristol Myers Squibb Compugen Immunogen Monoclonal Antibody Therapy

Is CTMX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.44
52 Week Low 6.25
Average Volume 879,033
200-Day Moving Average 7.49
50-Day Moving Average 8.09
20-Day Moving Average 7.74
10-Day Moving Average 7.67
Average True Range 0.53
ADX 12.34
+DI 34.14
-DI 20.38
Chandelier Exit (Long, 3 ATRs ) 7.49
Chandelier Exit (Short, 3 ATRs ) 8.10
Upper Bollinger Band 8.76
Lower Bollinger Band 6.72
Percent B (%b) 1.1
BandWidth 26.31
MACD Line 0.04
MACD Signal Line -0.11
MACD Histogram 0.1496
Fundamentals Value
Market Cap 414.17 Million
Num Shares 46.2 Million
EPS -2.20
Price-to-Earnings (P/E) Ratio -4.07
Price-to-Sales 3.74
Price-to-Book 7.24
PEG Ratio -1.80
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.03
Resistance 3 (R3) 9.93 9.49 9.85
Resistance 2 (R2) 9.49 9.22 9.53 9.79
Resistance 1 (R1) 9.22 9.05 9.36 9.32 9.73
Pivot Point 8.78 8.78 8.84 8.82 8.78
Support 1 (S1) 8.51 8.51 8.65 8.61 8.19
Support 2 (S2) 8.07 8.34 8.11 8.13
Support 3 (S3) 7.80 8.07 8.07
Support 4 (S4) 7.90